## **Core Concept**
Female pseudohermaphroditism, now more commonly referred to as **46,XX disorders of sex development (DSD)**, occurs when an individual with a 46,XX karyotype (typically female) has genitalia that are masculinized or ambiguous. This condition arises due to an excess of androgens during fetal development.

## **Why the Correct Answer is Right**
The correct answer involves conditions leading to an overproduction or increased effect of androgens in a genetically female (46,XX) fetus. The most common cause is **Congenital Adrenal Hyperplasia (CAH)**, specifically the 21-hydroxylase deficiency form, which accounts for about 90-95% of cases. This deficiency leads to a decrease in the production of cortisol and aldosterone, with a concomitant increase in the production of androgens due to the shunting of precursors towards the androgen pathway.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not specified, but if it does not relate to androgen excess or abnormal androgen action, it would be incorrect.
- **Option B:** Similarly, without specifics, if this option does not pertain to causes of androgen excess or increased androgen sensitivity, it would not be correct.
- **Option C:** Again, lacking details, if this does not directly relate to the known causes of female pseudohermaphroditism or 46,XX DSD, such as androgen-producing tumors (less common), maternal androgen exposure, or other genetic causes, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency** is the most common cause of female pseudohermaphroditism. Early diagnosis and treatment are crucial to prevent virilization and to manage associated electrolyte imbalances. A classic clinical correlation is the presence of **salt-wasting** in some but not all forms of CAH, which is a critical distinction for management.

## **Correct Answer:** C. Congenital adrenal hyperplasia.